NetworkNewsBreaks – CytoDyn Inc. (CYDY) Adds Dr. Scott A. Kelly to Board of Directors
Biotechnology company CytoDyn Inc. (OTCQB: CYDY) this morning announced the addition of Scott A. Kelly, M.D., FAAPMR, to its board of directors, effective April 10, 2017. With this appointment, the company’s board of directors now includes eight members. “Scott is passionate about target-specific treatments and personalized medicine that improve the lives of patients,” Denis R. Burger, Ph.D., vice chairman and chief science officer of CytoDyn, stated in the news release. “He has been a supporter and significant investor in CytoDyn, and we look forward to his contributions to our Company as a member of our Board.” Kelly brings considerable industry…







